Jun 17, 2026 08:45AM
Jun 17, 2026 08:45AM
May 5, 2026 07:22AM
May 5, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 28, 2026 07:00AM Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Apr 13, 2026 07:01AM
Apr 13, 2026 07:00AM
Feb 17, 2026 07:02AM
Feb 17, 2026 07:00AM
Feb 5, 2026 07:43AM
Feb 5, 2026 07:00AM
Jan 21, 2026 07:00AM MIAX sells 90% of derivatives exchange to Robinhood-Susquehanna venture
Jan 21, 2026 07:00AM
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 4, 2025 07:12AM
Nov 4, 2025 07:05AM Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Nov 4, 2025 07:02AM
Nov 4, 2025 07:00AM
Oct 28, 2025 07:00AM
Sep 30, 2025 06:21AM
Sep 30, 2025 06:21AM
Aug 12, 2025 07:01AM
Aug 12, 2025 07:00AM Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI™ in NPDR
Aug 5, 2025 11:11AM
Aug 5, 2025 11:07AM
Aug 5, 2025 07:13AM
Aug 5, 2025 07:00AM
Jul 29, 2025 07:00AM
May 5, 2025 07:04AM
May 5, 2025 07:00AM Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
Apr 28, 2025 07:00AM
Mar 4, 2025 06:42AM
Mar 3, 2025 07:10AM
Mar 3, 2025 07:00AM
Feb 24, 2025 07:00AM
Jan 14, 2025 07:03AM
Jan 14, 2025 07:00AM Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
Dec 2, 2024 07:30AM
Nov 15, 2024 06:51AM
Nov 14, 2024 07:04AM
Nov 14, 2024 07:00AM
Nov 12, 2024 07:31AM
Nov 12, 2024 07:30AM
Nov 6, 2024 07:30AM Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024
Oct 15, 2024 07:31AM

1,199,832 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All